Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea-pig
- 1 February 1982
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 78 (1), 71-79
- https://doi.org/10.1016/0014-2999(82)90373-9
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Present concepts on the mechanisms of platelet aggregationBiochemical Pharmacology, 1981
- Release of platelet‐activating factor (PAF‐acether) from alveolar macrophages by the calcium ionophore A 23187 and phagocytosisEuropean Journal of Clinical Investigation, 1980
- Platelet-Activating Factor (PAF-Acether) Secretion from Platelets: Effect of Aggregating AgentsBritish Journal of Haematology, 1980
- Platelet activating factor (PAF‐acether): total synthesis of 1‐O‐octadecyl 2‐O‐acetyl sn‐glycero‐3‐phosphoryl cholineFEBS Letters, 1980
- Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivativesEuropean Journal of Pharmacology, 1980
- Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.The Journal of Immunology, 1980
- The role of platelet-activating factor in platelet aggregationNature, 1979
- ROLE OF PLATELETS IN ASPIRIN-SENSITIVE BRONCHOCONSTRICTION IN THE GUINEA-PIG; INTERACTIONS WITH SALICYLIC ACIDBritish Journal of Pharmacology, 1978
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972
- Antagonism by Aspirin and Fenamates of Bronchoconstriction and Nociception induced by Adenosine-5′-triphosphateNature, 1966